MPO and myelodysplastic syndrome: Overall, the diagnostic performance attributes of peripheral blood neutrophil myeloperoxidase expression, as quantified by flow cytometric analysis, are supported by a retrospective case–control study and three prospective validation studies totalling 311 patients, of whom 119 (38%) received a reference diagnosis of MDS.31